Product
D930
1 clinical trial
1 indication
Indication
GlaucomaClinical trial
A Randomized, Open-label, 2-period, Parallel Group, Multiple-dose Phase 1 Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930, in Healthy Male SubjectsStatus: Completed, Estimated PCD: 2022-10-18